Loading company…
RiboPro develops and manufactures mRNA and lipid nanoparticle formulations for RNA-based therapeutics.
Founded in 2020, RiboPro offers mRNA design, GMP-grade manufacturing and lipid nanoparticle formulation services for biopharma companies, research institutions and health networks. Its work includes applications in chronic kidney disease, eye diseases and immunotherapy. The company is based in the Netherlands. In October 2024, it raised an undisclosed amount of venture funding from Mountainview Capital Partners, with participation from Rockstart, BOM Brabant Ventures and Vlasroot.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in